Company / PP&E (Net)
TENAX THERAPEUTICS, INC. PP&E (Net) History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$19.1K
FY2016
5-year range
$19.1K / $124.4K
FY2012-FY2016
Trend
-84.6%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $124,374 to $19,105 over the past 2 years.
Based on SEC 10-K filings.
$19,105 in FY2016 with a 3-year CAGR of -54.7%.
Declined from $124,374 to $19,105 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -54.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -54.7%, indicating a declining trend.
- In FY2016, pp&e (net) decreased 84.6% year-over-year.
- Peak pp&e (net) was recorded in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2016 | $19.1K | -84.6% |
| FY2015 | $124.4K | +0.0% |
| FY2014 | $124.4K | -39.4% |
| FY2013 | $205.4K | -30.0% |
| FY2012 | $293.6K | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026